Back to LCTX
Versant Capital Management, Inc → LCTX
Versant Capital Management, Inc LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
5
Latest value
$23K
Q3 2026
Peak value
$32K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $850 |
| Q4 2025 | $9K |
| Q1 2026 | $32K |
| Q2 2026 | $19K |
| Q3 2026 | $23K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $23K | 667 | — | — |
| Q2 2026 | $19K | 440 | — | — |
| Q1 2026 | $32K | 967 | — | — |
| Q4 2025 | $9K | 257 | — | — |
| Q3 2025 | $850 | 22 | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M